Clearside Biomedical
CLSD
CLSD
66 hedge funds and large institutions have $122M invested in Clearside Biomedical in 2021 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 23 increasing their positions, 10 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
27% more capital invested
Capital invested by funds: $95.7M → $122M (+$25.9M)
25% more funds holding
Funds holding: 53 → 66 (+13)
0.1% less ownership
Funds ownership: 34.15% → 34.05% (-0.1%)
Holders
66
Holding in Top 10
3
Calls
$4.57M
Puts
$3.09M
Top Buyers
| 1 | +$3.12M | |
| 2 | +$2.03M | |
| 3 | +$1.66M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$1.2M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$671K |
Top Sellers
| 1 | -$5.67M | |
| 2 | -$1.55M | |
| 3 | -$1.06M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$509K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$181K |